Walmart launches low-priced own brand analog insulin in US
Al JazeeraThe world’s largest retailer is offering affordable insulin drugs for millions of Americans living with diabetes. Walmart announced on Tuesday the launch of its first-ever private brand analog insulin in its United States pharmacies – a move the world’s largest retailer says could help its millions of US customers living with diabetes cope with the blistering price of prescription drugs. “We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions,” Walmart said in a press release. “We also know this is a condition that disproportionately impacts underserved populations.” The retailing giant’s private ReliOn NovoLog Insulin products include analog insulin vials that sell for $72.88 and a FlexPen priced at $85.88. ReliOn NovoLog is a rapid-acting analog insulin used to control high blood sugar in adults and children suffering from diabetes.
History of this topic
Novo Nordisk to slash insulin drug for diabetes price by up to 75%
The Independent
Lilly plans to slash some insulin prices, expand cost cap
Associated PressDiscover Related
